Bristol-Myers Squibb
Price & Volume
Stats
See more52W Range | $41.45-$62.24 |
Market Cap | $116.7B |
Shares Short | 36M |
Financials
See moreRevenue (12 Mos) | $48.4B |
Revenue Growth (YoY) | 2.6% |
Gross Profit (12 Mos) | $34.8B |
Diluted EPS | $3.57 |
News
See moreYahoo Finance • 15 hours ago
Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
Yahoo Finance • 15 hours ago
Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs
Yahoo Finance • 4 days ago
This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative.
Yahoo Finance • 4 days ago
Kardigan targets IPO to support cardiology pipeline progression
About
CEO | Dr. Christopher S. Boerner Ph.D. |
CFO | Mr. David V. Elkins |
Address | Route 206 & Province Line Road, Princeton, NJ, United States, 08543 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 32,500 |